Utah Medical Products Inc (NASDAQ:UTMD) Shorts Rose By 11.62% As Of Jun 27, 2018

June 27, 2018 - By Daniel Mitchell

During 2018 Q1 the big money sentiment decreased to 1.21. That’s change of 0.54, from 2017Q4’s 1.75. 8 investors sold all, 25 reduced holdings as Utah Medical Products, Inc. ratio worsened. 22 increased stakes while 18 funds took stakes. Funds hold 2.48 million shares thus 3.44% more from 2017Q4’s 2.40 million shares.
Citigroup reported 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Fmr Ltd Com stated it has 551,528 shs or 0.01% of all its holdings. Sei Invests owns 4 shs. Moreover, Advisory Ltd Limited Liability Company has 0.03% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 3,725 shs. Stratos Wealth Partners Ltd has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD). Bridgeway Capital Mgmt Inc invested 0.02% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). New York-based Bnp Paribas Arbitrage Sa has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Deutsche Bank & Trust Ag reported 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Cambridge Inv accumulated 3,546 shs. Rhumbline Advisers reported 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Everett Harris & Ca owns 3,545 shs. Ancora Advisors Lc, Us-based fund reported 79,587 shs. Wedge Capital Mgmt L Limited Partnership Nc accumulated 0% or 4,400 shs. Ativo Capital Lc holds 17,526 shs or 0.49% of its capital. Schwab Charles Inv Mngmt owns 7,465 shs or 0% of their US capital.

Utah Medical Products, Inc. had 17 selling transactions and 0 insider buys since February 2, 2018. This’s net activity of $4.97 million. On Thursday, May 3 $182,272 worth of Utah Medical Products, Inc. (NASDAQ:UTMD) was sold by HOYER ERNST G. CORNWELL KEVIN L sold $646,665 worth of Utah Medical Products, Inc. (NASDAQ:UTMD) on Wednesday, March 7.

Utah Medical Products Inc (NASDAQ:UTMD) had an increase of its short interest by 11.62%. It was issued in June by FINRA the 65,300 short interest on UTMD. The 58,500 previous shares are up with 11.62%. Previous UTMD’s position will need 5 days to recover. It has 12,900 average volume. Float short on Utah Medical Products Inc is 2.05%.

UTMD touched $113.4 during the last trading session after $1.15 change.Currently Utah Medical Products, Inc. is uptrending after 57.69% change in last June 27, 2017. UTMD has also 6,392 shares volume. The stock outperformed the S&P 500 by 45.12%.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide.The company has $423.04 million market cap. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.46.82 is the P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

There’s an important Utah Medical Products, Inc. (NASDAQ:UTMD) news brought out by Benzinga.com. It’s a report titled: “Benzinga’s Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares” on June 19, 2018.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: